Latest Sir2 Stories
Treatment that increases brain levels of a crucial regulatory enzyme may slow the loss of brain cells that characterize Huntington’s disease (HD) and other neurodegenerative disorders, according to this study.
Cancer cells are essentially immortal.
Treatment that increases brain levels of an important regulatory enzyme may slow the loss of brain cells that characterizes Huntington's disease (HD) and other neurodegenerative disorders.
New research suggests that anti-ageing face creams and supplements, that actively use a 'miracle ingredient' commonly found in red wine, are a complete waste of time and money, and do nothing to improve your odds of living a longer life.
Researchers from the Kimmel Cancer Center at Jefferson and two other institutions have discovered new evidence that suggests the "longevity" protein SIRT1, known for its life-spanning effects in different species, can inhibit the development of a known precursor to prostate cancer, prostatic intraepithelial neoplasia (PIN).
High doses or prolonged use of glucosamine causes the death of pancreatic cells and could increase the risk of developing diabetes.
A new study uncovers a protein modification that may contribute to the formation of neuron-damaging neurofibrillary tangles in the human brain.
Scientists at the Gladstone Institute of Neurological Disease (GIND) have uncovered new approaches to reduce toxic proteins in Alzheimer's disease (AD) and other neurodegenerative diseases.
Researchers watched two groups of mice, both nearing the end of a two-day fast.
MIT biologists report that they have discovered the first link between the amyloid plaques that form in the brains of Alzheimer's patients and a gene previously implicated in the aging process, SIRT1.